Nerve Conduction Blockade in the Sciatic Nerve Prevents but Does Not Reverse the Activation of p38 Mitogen-activated Protein Kinase in Spinal Microglia in the Rat Spared Nerve Injury Model
- 1 August 2007
- journal article
- abstracts
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 107 (2), 312-321
- https://doi.org/10.1097/01.anes.0000270759.11086.e7
Abstract
Background Current evidence indicates that p38 mitogen-activated protein kinase activation in spinal microglia contributes to the development of neuropathic pain. However, how nerve injury activates p38 in spinal microglia is incompletely unknown. Nerve injury-induced ectopic spontaneous activity is essential for the generation of neuropathic pain. The authors examined whether peripheral neural activity is necessary for p38 activation in spinal microglia. Methods To examine whether spinal microglia activation depends on peripheral activity in the rat spared nerve injury (SNI) model, the authors blocked conduction in the sciatic nerve before or 2 days after SNI. The block was produced by applying bupivacaine-loaded microspheres above the nerve injury site. The p38 activation was examined by p38 phosphorylation using a phosphorylated p38 antibody, and neuropathic pain-related behavior was evaluated before and after intrathecal infusion of a p38 inhibitor. Results Three days after SNI, there was a marked p38 activation in the medial two thirds of the dorsal horn, where the injured tibial and peroneal nerves terminated and where isolectin B4 staining was lost. Phosphorylated p38 was only colocalized with the microglial surface marker OX-42, indicating a microglial localization of phosphorylated p38 in the SNI model. Bupivacaine microspheres produced persistent block (loss of sensory and motor function) of the sciatic nerve for the whole period of the study (3 days). This blockade prevented but did not reverse p38 activation in spinal microglia. Intrathecal infusion of the p38 inhibitor FR167653 prevented and reversed mechanical allodynia on post-SNI day 3. Conclusions After nerve injury, activity in the peripheral nerve is required for the induction but not the maintenance of p38 activation in spinal microglia.Keywords
This publication has 51 references indexed in Scilit:
- BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic painNature, 2005
- The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathyProceedings of the National Academy of Sciences of the United States of America, 2005
- Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ gliaTrends in Neurosciences, 2005
- Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditionsEuropean Journal of Neuroscience, 2004
- P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injuryNature, 2003
- Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2Proceedings of the National Academy of Sciences of the United States of America, 2003
- p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic PainJournal of Neuroscience, 2003
- Glial activation: a driving force for pathological painTrends in Neurosciences, 2001
- The role of neuroinflammation and neuroimmune activation in persistent painPain, 2001
- Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the ratJournal of Neuroimmunology, 1997